Process development for treatment of highly polluted groundwater including NOM and arsenic removal

2014 ◽  
Vol 9 (3) ◽  
pp. 409-416
Author(s):  
B. Pelivanoski ◽  
K. Pirke
Keyword(s):  
Drinking Water ◽  
Arsenic Removal ◽  
Process Development ◽  
World Health Organisation ◽  
World Health ◽  
Multiple Treatment ◽  
The World ◽  
Treatment Technologies ◽  
High Concentrations ◽  
Two Stages

One of the worst environmental problems facing humanity in regard to contamination in drinking water is arsenic. The World Health Organisation has set a standard 10 μg/l for arsenic in drinking water. Arsenic is a natural element that is present in many regions of the world. The groundwater can be heavily polluted in these areas, and often no other water sources are available. The case study presented here is situated in northern Serbia. The groundwater shows concentrations up to 135 μg/l with an average of 110 μg/l of arsenic. The additional high concentrations of natural organic matter, phosphates, dissolved methane, volatile organic carbon and ammonia boron and sodium further complicate the treatment. Different treatment technologies have been tested over the past decades but proved either inefficient or not economical. The pilot testing period started in September 2012 and ended in August 2013. The most stable and economical process was then further optimized and adjusted. The process comprises multiple treatment stages including stripping, precipitation, bio-filtration and two stages ion-exchange as well as partial reverse osmoses. The process design guaranteed outflow values defined according to the European directive 98/83/EC.

scholarly journals Arsenic Removal from Peruvian Drinking Water by Milk Protein Nanofibril-Carbon Filters: A Field Study

2021 ◽  
Author(s):  
Sreenath Bolisetty ◽  
Akram Rahimi ◽  
Raffaele Mezzenga
Keyword(s):  
Water Quality ◽  
Drinking Water ◽  
Milk Protein ◽  
Arsenic Removal ◽  
Tap Water ◽  
Local Population ◽  
World Health ◽  
The World ◽  
Tap Water Quality ◽  
Health Organization

Tap water quality in Peru fails to meet the world health organization (WHO) drinking water standards; consequently, the local population in Peru has been exposed over the last years to...

scholarly journals An international review of the challenges associated with securing buy-in for water safety plans within providers of drinking water supplies

2010 ◽  
Vol 8 (2) ◽  
pp. 387-398 ◽  
Author(s):  
Corinna Summerill ◽  
Jen Smith ◽  
James Webster ◽  
Simon Pollard
Keyword(s):  
Drinking Water ◽  
World Health Organisation ◽  
World Health ◽  
International Review ◽  
Water Safety ◽  
Financial Efficiency ◽  
The Public ◽  
Quality Guidelines ◽  
The World ◽  
Water Safety Plans

Since publication of the 3rd Edition of the World Health Organisation (WHO) Drinking Water Quality guidelines, global adoption of water safety plans (WSPs) has been gathering momentum. Most guidance lists managerial commitment and ‘buy-in’ as critical to the success of WSP implementation; yet the detail on how to generate it is lacking. This commentary discusses aspects of managerial commitment to WSPs. We argue that the public health motivator should be clearer and a paramount objective and not lost among other, albeit legitimate, drivers such as political or regulatory pressures and financial efficiency.

scholarly journals An overview of main arsenic removal technologies

2018 ◽  
Vol 11 (2) ◽  
pp. 107-113 ◽  
Author(s):  
Ronald Zakhar ◽  
Ján Derco ◽  
František Čacho
Keyword(s):  
Drinking Water ◽  
Membrane Filtration ◽  
Arsenic Removal ◽  
Chemical Precipitation ◽  
Contaminated Water ◽  
The World ◽  
Removal Processes ◽  
Removal Technologies ◽  
High Concentrations ◽  
Exchange Membrane

Abstract Arsenic (As) is metalloid, naturally present in the environment but also introduced by human activities. It is toxic and carcinogenic and its exposure to low or high concentrations can be fatal to human health. Arsenic contamination in drinking water threatens more than 150 million peoples all over the world. Therefore, treatment of As contaminated water is of unquestionable importance. The present review begins with an overview of As chemistry, distribution and toxicity, which are relevant aspects to understand and develop remediation techniques. The most common As removal processes (chemical precipitation, adsorption, ion exchange, membrane filtration, phytoremediation and electrocoagulation) are presented with discussion of their advantages, drawbacks and the main recent achievements.

A Collaborative Study to Establish the Second International Standard for Streptokinase

1990 ◽  
Vol 64 (02) ◽  
pp. 267-269 ◽  
Author(s):  
A B Heath ◽  
P J Gaffney
Keyword(s):  
High Purity ◽  
Collaborative Study ◽  
World Health Organisation ◽  
World Health ◽  
Clot Lysis ◽  
Current Standard ◽  
International Standard ◽  
Accelerated Degradation ◽  
The World ◽  
International Collaborative Study

SummaryAn International Standard for Streptokinase - Streptodomase (62/7) has been used to calibrate high purity clinical batches of SK since 1965. An international collaborative study, involving six laboratories, was undertaken to replace this standard with a high purity standard for SK. Two candidate preparations (88/826 and 88/824) were compared by a clot lysis assay with the current standard (62/7). Potencies of 671 i.u. and 461 i.u. were established for preparations A (88/826) and B (88/824), respectively.Either preparation appeared suitable to serve as a standard for SK. However, each ampoule of preparation A (88/826) contains a more appropriate amount of SK activity for potency testing, and is therefore preferred. Accelerated degradation tests indicate that preparation A (88/826) is very stable.The high purity streptokinase preparation, coded 88/826, has been established by the World Health Organisation as the 2nd International Standard for Streptokinase, with an assigned potency of 700 i.u. per ampoule.

Comparative docking of SARS-CoV-2 receptors antagonists from repurposing drugs

2020 ◽  
Author(s):  
Micael Davi Lima de Oliveira ◽  
Kelson Mota Teixeira de Oliveira
Keyword(s):  
World Health Organisation ◽  
World Health ◽  
Lung Cells ◽  
The Novel ◽  
High Modulation ◽  
Main Protease ◽  
The World ◽  
Novel Coronavirus ◽  
Viral Receptors ◽  
Theoretical Results

According to the World Health Organisation, until 16 June, 2020, the number of confirmed and notified cases of COVID-19 has already exceeded 7.9 million with approximately 434 thousand deaths worldwide. This research aimed to find repurposing antagonists, that may inhibit the activity of the main protease (Mpro) of the SARS-CoV-2 virus, as well as partially modulate the ACE2 receptors largely found in lung cells, and reduce viral replication by inhibiting Nsp12 RNA polymerase. Docking molecular simulations were performed among a total of 60 structures, most of all, published in the literature against the novel coronavirus. The theoretical results indicated that, in comparative terms, paritaprevir, ivermectin, ledipasvir, and simeprevir, are among the most theoretical promising drugs in remission of symptoms from the disease. Furthermore, also corroborate indinavir to the high modulation in viral receptors. The second group of promising drugs includes remdesivir and azithromycin. The repurposing drugs HCQ and chloroquine were not effective in comparative terms to other drugs, as monotherapies, against SARS-CoV-2 infection.

Use of Phosphatidylcholine in the Treatment of Localized Fat Deposits. Results and expectations

2017 ◽  
Vol 68 (7) ◽  
pp. 1438-1441 ◽  
Author(s):  
Sorin Berbece ◽  
Dan Iliescu ◽  
Valeriu Ardeleanu ◽  
Alexandru Nicolau ◽  
Radu Cristian Jecan
Keyword(s):  
World Health Organisation ◽  
Normal Weight ◽  
World Health ◽  
Basic Substance ◽  
Physical Exercises ◽  
Fat Deposits ◽  
The World ◽  
The Common ◽  
Global Health Problem ◽  
Over Time

Obesity represents a global health problem. According to the latest studies released by the World Health Organisation (WHO), 1.7 billion currently in excess of normal weight individuals, of which approx. 75% are overweight (body mass index - BMI 25 to 30). The common form of excess adipose tissue manifestation in overweight individuals is localized fat deposits with high (abdominal) or low (buttocks and thighs) disposition. Although the overweight can be corrected relatively easy by changing behavioral habits or food, a constant physical exercises program or following a diet food are not accessible to all through the efforts of will, financial and time involved. Several methods have been studied and tested over time to eliminate more or less invasive fat deposits with varying efficacy and adverse effects. Chemical lipolysis using phosphatidylcholine as the basic substance was initially used in hypercholesterolemia and its complications and was rapidly adopted in mesotherapy techniques for the treatment of fat deposits. This study reveals the results obtained using Dermastabilon on a sample of 16 patients, the time allocated to treatment and discomfort being minimal, and rapid and notable results. There were no side effects.

The Undiscovered Potential of Essential Oils for Treating SARS-CoV-2 (COVID-19)

2020 ◽  
Vol 26 (41) ◽  
pp. 5261-5277
Author(s):  
Peter J. Wilkin ◽  
Minnatallah Al-Yozbaki ◽  
Alex George ◽  
Girish K. Gupta ◽  
Cornelia M. Wilson
Keyword(s):  
Essential Oils ◽  
Clinical Symptoms ◽  
Synergistic Effects ◽  
World Health Organisation ◽  
Diagnostic Techniques ◽  
World Health ◽  
Clinical Aspects ◽  
Traditional Use ◽  
In Silico Studies ◽  
The World

On 11th March 2020, the World Health Organisation (WHO) announced a pandemic caused by a novel beta-coronavirus SARS-CoV-2, designated COVID-19. The virus emerged in December 2019 in Wuhan, China, has spread across the world as a global pandemic. The traditional use of medicines from plants can be traced back to 60,000 years. Global interest in the development of drugs from natural products has increased greatly during the last few decades. Essential oils (EOs) have been studied through the centuries and are known to possess various pharmaceutical properties. In the present review, we have highlighted the current biology, epidemiology, various clinical aspects, different diagnostic techniques, clinical symptoms, and management of COVID-19. An overview of the antiviral action of EOs, along with their proposed mechanism of action and in silico studies conducted, is described. The reported studies of EOs' antiviral activity highlight the baseline data about the additive and/or synergistic effects among primary or secondary phytoconstituents found in individual oils, combinations or blends of oils and between EOs and antiviral drugs. It is hoped that further research will provide better insights into EOs' potential to limit viral infection and aid in providing solutions through natural, therapeutically active agents.

scholarly journals Seroprevalence of SARS-CoV-2, Symptom Profiles and Sero-Neutralization in a Suburban Area, France

Viruses ◽  
2021 ◽  
Vol 13 (6) ◽  
pp. 1076
Author(s):  
Anne Gégout Petit ◽  
Hélène Jeulin ◽  
Karine Legrand ◽  
Nicolas Jay ◽  
Agathe Bochnakian ◽  
...  
Keyword(s):  
Odds Ratio ◽  
World Health Organisation ◽  
World Health ◽  
Preventive Effect ◽  
Neutralization Activity ◽  
Symptom Profiles ◽  
The World ◽  
Household Members ◽  
Total Immunoglobulin

The World Health Organisation recommends monitoring the circulation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We investigated anti–SARS-CoV-2 total immunoglobulin (IgT) antibody seroprevalence and in vitro sero-neutralization in Nancy, France, in spring 2020. Individuals were randomly sampled from electoral lists and invited with household members over 5 years old to be tested for anti–SARS-CoV-2 (IgT, i.e., IgA/IgG/IgM) antibodies by ELISA (Bio-rad); the sero-neutralization activity was evaluated on Vero CCL-81 cells. Among 2006 individuals, the raw seroprevalence was 2.1% (95% confidence interval 1.5 to 2.9), was highest for 20- to 34-year-old participants (4.7% (2.3 to 8.4)), within than out of socially deprived area (2.5% vs. 1%, p = 0.02) and with than without intra-family infection (p < 10−6). Moreover, 25% of participants presented at least one COVID-19 symptom associated with SARS-CoV-2 positivity (p < 10−13), with highly discriminant anosmia or ageusia (odds ratio 27.8 [13.9 to 54.5]); 16.3% (6.8 to 30.7) of seropositive individuals were asymptomatic. Positive sero-neutralization was demonstrated in vitro for 31/43 seropositive subjects. Regarding the very low seroprevalence, a preventive effect of the lockdown in March 2020 can be assumed for the summer, but a second COVID-19 wave, as expected, could be subsequently observed in this poorly immunized population.

Sign in / Sign up

Export Citation Format

Share Document